Serves as the senior regional clinical strategist for GE HealthCare's Amyloid PET portfolio
Drives clinical care pathway differentiation with radiology and imaging center decision makers
Responsible for shaping and driving large-scale clinical differentiation strategy
Leads strategic KOL partnerships and influences regional commercial planning across multiple product lines
Requires specialized and comprehensive knowledge across PET radiopharmaceutical diagnostics, quantification methodologies, reimbursement considerations, and evolving diagnostic care pathways
Defines engagement frameworks that strengthen competitive positioning and long-term portfolio growth
Influences development of regional strategy and contributes to broader commercial planning discussions
Integrates insights from Sales, Marketing, Product Marketing, and external clinical stakeholders to optimize portfolio positioning
Uses high level of judgment to address complex clinical, operational, and commercial challenges
Constructs strategic recommendations that impact territory planning and resource allocation
May lead high-visibility regional or cross-functional initiatives
Communicates difficult or sensitive information at executive levels
Mentors senior team members and elevates overall clinical capability across the region.

5+ years of experience as a practicing CNMT
Experience working with advanced PET radiopharmaceutical diagnostics
Proven experience working across teams and cross-functional collaboration
Strong strategic thinking and financial acumen
Excellent communication skills
Ability to manage complex projects with multiple stakeholders in a fast-paced environment
Demonstrated ability to work in matrixed organizations with success increasing levels of responsibility
Willingness to travel up to 80% of the time in field and with customers and supporting commercial events

Amyloid PET Clinical Consultant

Key skills